Abbott Header Logo
Logo Image

ALINITY m HCV ASSAY

For In Vitro Diagnostic Use.

ALINITY m HCV ASSAY
ALINITY m HCV ASSAY
ALINITY m HCV ASSAY

Accurate quantitation is critical to guide diagnosis to cure Hepatitis C. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma.

  • Dual probe assay within a highly conserved target region of the virus.
  • Accurate quantitation across all genotypes provide confidence in tests results.
  • Streamlined and concurrent HCV confirmation and viral load result from one sample (plasma or serum) to help provide laboratories and physicians with a solution from Confirmation to Clinical Management.

The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for use with the automated Alinity m System to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma. The Alinity m HCV assay is intended for use in the clinical management of HCV-infected patients undergoing antiviral therapy in conjunction with clinical presentation and other laboratory markers. The Alinity m HCV assay may also be used as a diagnostic test to confirm active HCV infection. The results from the Alinity m HCV assay must be interpreted within the context of all relevant clinical and laboratory findings. This assay is not intended to be used in screening blood, blood products, tissue, or organ donors for HCV.

 

 

ORDERING INFO

REQUEST INFO
ALINITY m HCV ASSAY PERFORMANCE
Limit of Detection (LoD)Plasma: Probit analysis determined that the concentration of HCV RNA in plasma detected with 95% probability was 5.11 IU/mL (95% CI 3.92 to 8.46 IU/mL). ermentum pharetra quam.
Serum: Probit analysis determined that the concentration of HCV RNA in serum detected with 95% probability was 5.11 IU/mL (95% CI 4.16 to 7.47 IU/mL).  
Linear Range12 IU/mL to 200,000,000 IU/mL 
Target RegionDual Target targeting 5’UTR  
Genotype Detection1, 2, 3, 4, 5, 6  
ConfirmatoryYes
Internal ControlYes 
Specimen Type

 

Plasma: Acid Citrate Dextrose (ACD); K2EDTA; K3EDTA, Plasma Preperation Tubes (PPT)*
Serum: Serum; Serum Separator Tubes (SST)*
*Gel tubes  
Input Volume600 µL 
PrecisionPrecision < 0.18 Total SD   
Standardization4th World Health Organization (WHO) [NIBSC code: 06/102; genotype 1]   
SpecificityOverall: 100.0% [95% CI: 99.2 to 100.0] 

Source: Alinity m HCV AMP kit PI: 53-608062/R9

 

Logo Image

© 2024 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Other trademarks are the property of their respective owners.

This Internet site that you have requested is intended for the residents of a particular country or countries and may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which this site is directed, contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?